Recruiting NA Obsessive-Compulsive Disorder

New treatment option for Obsessive-Compulsive Disorder

Official title Family Involvement in CBGT of OCD: a Randomized Controlled Trial

ClinicalTrials.gov ID: NCT04071990

What this study is testing

What it's testing
With a lifetime prevalence of 1-3% Obsessive-Compulsive Disorder (OCD) is a chronic and disabling psychiatric disorder with considerable burden for the individual and society. Cognitive-behavioural group therapy (CBGT) is effective in reducing the intensity of OCD symptoms and it improves the OCD patient's quality of life.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 65

You may be able to join if

  • the OCD patient with a score of at least 16 on Y-BOCS
  • patient and family member fluent in Dutch
  • patient and family member both willing to attend all treatment sessions together.

You likely can't join if

  • current severe suicidality
  • current substance abuse
  • psychotic symptoms and
  • OCD treated with deep brain stimulation

The study team makes the final eligibility decision.

Where it's taking place

  • Ghent, Belgium

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Ghent, Belgium. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.